Summit Therapeutics Inc vs United Microelectronics Corp — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while United Microelectronics Corp trades at $21.14 (market cap $51.00B). The key difference: United Microelectronics Corp is far larger — about 4.9× Summit Therapeutics Inc's market cap, and United Microelectronics Corp pays a 2.03% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | UMC | |
|---|---|---|
Market Cap | $10.48B | $51.00B |
Sector | Health | Technology |
52-Week High | $29.32 | $28.02 |
52-Week Low | $13.05 | $6.58 |
Enterprise Value | $9.90B | $48.57B |
Dividend Yield | — | 2.03% |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →